Market revenue in 2023 | USD 388.4 million |
Market revenue in 2030 | USD 483.3 million |
Growth rate | 3.2% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Kits & Reagents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Lateral Flow Readers |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Roche, Bio-Rad Laboratories Inc, BioMerieux SA, QuidelOrtho Corp, Hologic Inc, PerkinElmer, Merck KGaA, BD, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lateral flow assays market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 68.56% in 2023. Horizon Databook has segmented the Germany lateral flow assays market based on kits & reagents, lateral flow readers covering the revenue growth of each sub-segment from 2018 to 2030.
Rise in prevalence of cardiovascular diseases in Germany is expected to boost market growth. Cardiovascular diseases are one of the leading causes of deaths in the country that account for approximately 40% of all deaths.
There is also an increase in the incidence of malaria due to rise in migrating individuals from malaria-endemic countries which is expected to boost market growth. Rise in the number of new entrants strategically collaborating with various companies to enhance rapid diagnostic technology is anticipated to boost market growth in Germany during the forecast period.
For instance, in August 2019, Expedeon AG signed a commercial agreement with Sona Nanotech, Inc. As per the agreement, Expedeon will be providing its bioconjugation technologies, gold nanoparticle, and expertise, whereas Sona Nanotech, Inc. will be offering its lateral flow developing services.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany lateral flow assays market , including forecasts for subscribers. This country databook contains high-level insights into Germany lateral flow assays market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account